MIM
LH icon

Meridiem Investment Management’s Labcorp LH Stock Holding History

Meridiem Investment Management’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$219M Sell
781,731
-197,640
-20% -$52M 5.87% 6
2026
Q1 		$261M Sell
979,371
-47,523
-5% -$12.9M 6.67% 3
2025
Q4 		$258M Sell
1,026,894
-30,431
-3% -$8.08M 5.44% 8
2025
Q3 		$304M Sell
1,057,325
-11,643
-1% -$3.12M 5.81% 6
2025
Q2 		$280M Sell
1,068,968
-197,720
-16% -$48.1M 5.1% 10
2025
Q1 		$295M Buy
1,266,688
+55,374
+5% +$13.4M 5.39% 7
2024
Q4 		$278M Sell
1,211,314
-6,246
-0.5% -$1.43M 4.97% 9
2024
Q3 		$272M Sell
1,217,560
-7,850
-0.6% -$1.73M 4.84% 11
2024
Q2 		$249M Buy
1,225,410
+49,240
+4% +$10M 4.68% 13
2024
Q1 		$257M Buy
1,176,170
+35,870
+3% +$7.9M 5.04% 13
2023
Q4 		$259M Buy
1,140,300
+279,628
+32% +$58.7M 5.59% 8
2023
Q3 		$173M Sell
860,672
-139,403
-14% -$29.4M 4.63% 12
2023
Q2 		$207M Buy
1,000,075
+3,343
+0.3% +$649K 5.34% 7
2023
Q1 		$196M Buy
996,732
+9,630
+1% +$1.98M 5.52% 7
2022
Q4 		$200M Buy
987,102
+18,311
+2% +$3.58M 6.19% 6
2022
Q3 		$171M Sell
968,791
-132,288
-12% -$27.1M 5.78% 4
2022
Q2 		$222M Buy
1,101,079
+162,109
+17% +$34.6M 6.1% 3
2022
Q1 		$213M Buy
938,970
+151,999
+19% +$35.7M 6.01% 4
2021
Q4 		$212M Sell
786,971
-22,841
-3% -$5.65M 6.41% 3
2021
Q3 		$196M Sell
809,812
-3,290
-0.4% -$829K 6.63% 4
2021
Q2 		$193M Buy
813,102
+13,369
+2% +$3.05M 6.99% 3
2021
Q1 		$175M Sell
799,733
-69,499
-8% -$13.9M 7.05% 3
2020
Q4 		$152M Buy
+869,232
New +$150M 7.95% 4

Other funds holding LH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Meridiem Investment Management's LH Position: Q2 2026 in Review

Meridiem Investment Management reduced its Labcorp (LH) stake by 20% in Q2 2026, selling an estimated $52M and leaving 781,731 shares worth $219M. The position accounts for 5.87% of the portfolio, ranked #6.

Meridiem Investment Management first reported a position in LH in Q4 2020 and has held it in 23 quarters since. The position peaked at $304M in Q3 2025. 1,058 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Meridiem Investment Management held 781,731 shares of Labcorp worth $219M as of Q2 2026.
  • Meridiem Investment Management sold 197,640 Labcorp shares in Q2 2026, an estimated $52M.
  • Labcorp made up 5.87% of Meridiem Investment Management's portfolio in Q2 2026, its #6 holding.
  • Meridiem Investment Management first reported a position in Labcorp in Q4 2020 and has held it in 23 quarters since.
  • Meridiem Investment Management's Labcorp position peaked at $304M in Q3 2025.
  • 1,058 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Meridiem Investment Management's 13F filing for Q2 2026, filed 11 Aug 2026.